Background: Successful implementation of malaria treatment policy depends on the prescription practices for patients with malaria. This paper describes prescription patterns and assesses factors associated with co-prescription of antibiotics and artemether-lumefantrine (AL) for patients presenting with fever in rural Tanzania.

Method: From June 2009 to September 2011, a cohort event monitoring program was conducted among all patients treated at 8 selected health facilities in Ifakara and Rufiji Health and Demographic Surveillance System (HDSS). It included all patients presenting with fever and prescribed with AL. Logistic regression was used to model the predictors on the outcome variable which is co-prescription of AL and antibiotics on a single clinical visit.

Results: A cohort of 11,648 was recruited and followed up with 92% presenting with fever. Presumptive treatment was used in 56% of patients treated with AL. On average 2.4 (1 - 7) drugs was prescribed per encounter, indicating co-prescription of AL with other drugs. Children under five had higher odds of AL and antibiotics co-prescription (OR = 0.63, 95% CI: 0.46 - 0.85) than those aged more than five years. Patients testing negative had higher odds (OR = 2.22, 95% CI: 1.65 - 2.97) of AL and antibiotics co-prescription. Patients receiving treatment from dispensaries had higher odds (OR = 1.45, 95% CI: 0.84 - 2.30) of AL and antibiotics co-prescription than those served in health centres even though the deference was not statistically significant.

Conclusion: Regardless the fact that Malaria is declining but due to lack of laboratories and mRDT in most health facilities in the rural areas, clinicians are still treating malaria presumptively. This leads them to prescribe more drugs to treat all possibilities.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866462PMC
http://dx.doi.org/10.1186/1471-2458-13-1097DOI Listing

Publication Analysis

Top Keywords

antibiotics co-prescription
16
presenting fever
16
patients presenting
12
higher odds
12
patients
8
fever rural
8
co-prescription antibiotics
8
patients treated
8
health facilities
8
co-prescription
7

Similar Publications

Article Synopsis
  • - The study aimed to assess the death risk in older adults taking low-dose methotrexate when also prescribed TMP-SMX compared to a cephalosporin.
  • - Researchers matched 1,602 adults on each antibiotic to analyze the 30-day outcomes, finding similar death rates but increased risks of hospitalization and infection with TMP-SMX.
  • - The conclusion indicated no higher death risk from TMP-SMX, but it was linked to increased hospitalization rates, suggesting that the benefits of this co-prescription need careful consideration.
View Article and Find Full Text PDF

Ceftriaxone stands as a cornerstone in global antibiotic therapy owing to its potent antibacterial activity, broad spectrum coverage, and low toxicity. Nevertheless, its efficacy is impeded by widespread inappropriate prescribing and utilization practices, significantly contributing to bacterial resistance. The aim of this study is to determine the overall national pooled prevalence of inappropriate ceftriaxone utilization and its predictor factors in Ethiopia.

View Article and Find Full Text PDF

Importance: Trimethoprim-sulfamethoxazole (TMP-SMX) may increase digoxin concentration, a medication with a narrow therapeutic index. Small changes in digoxin concentration could predispose individuals to the risk of toxicity.

Objective: To characterize the risk of digoxin toxicity in older adults taking digoxin following co-prescription of TMP-SMX compared with co-prescription of amoxicillin.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to analyze the usage patterns of proton-pump inhibitors (PPIs) in prescriptions and to promote evidence-based recommendations for incorporating probiotics alongside PPIs for various gastrointestinal conditions.
  • - A survey of 1,007 healthcare professionals revealed that over 43% believed 10-30% of patients were on long-term PPI therapy, with most often prescribing PPIs for GERD-related gastritis and peptic ulcers; 91% noted that long-term PPI use disrupts gut flora.
  • - The findings highlighted a strong consensus among healthcare professionals (85%) on the benefits of prescribing probiotics to prevent gastrointestinal issues linked to PPI use, emphasizing a trend towards co-prescription to enhance patient health.
View Article and Find Full Text PDF

Background: The increased availability and use of malaria rapid diagnostic test (RDT) by primary healthcare (PHC) workers has made universal diagnostic testing before malaria treatment more feasible. However, to meaningfully resolve the problem of over-treatment with artemisinin-based combination therapy and the heightened risk of selection pressure and drug resistance, there should be appropriate response (non-prescription of anti-malarial drugs) following a negative RDT result by PHC workers. This study explored the determinants of the use of RDT and anti-malarial drug prescription practices by PHC workers in Ebonyi state, Nigeria.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!